What is the CVSS score of CVE-2021-1733?

CVE-2021-1733 has a CVSS 3.1 base score of 7.8 (High). CVSS vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 0.5%.

Is there a patch available for CVE-2021-1733?

Yes, a patch is available for CVE-2021-1733. Update the affected software to the latest version immediately.

Psexec CVE-2021-1733

HIGH

Improper Privilege Management (CWE-269)

2021-02-25 secure@microsoft.com

Privilege Escalation Psexec

7.8

CVSS 3.1 · Vendor: microsoft

Severity by source

Vendor (microsoft) PRIMARY

7.8 HIGH

AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from Vendor (microsoft) · only source for this CVE.

CVSS VectorVendor: microsoft

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Local

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Feb 25, 2021 - 23:15 cve.org

HIGH 7.8

DescriptionCVE.org

Sysinternals PsExec Elevation of Privilege Vulnerability

AnalysisAI

Sysinternals PsExec Elevation of Privilege Vulnerability. Rated high severity (CVSS 7.8), this vulnerability is low attack complexity. This Improper Privilege Management vulnerability could allow attackers to escalate privileges to gain unauthorized elevated access.

Technical ContextAI

This vulnerability is classified as Improper Privilege Management (CWE-269), which allows attackers to escalate privileges to gain unauthorized elevated access. Affected products include: Microsoft Psexec.

RemediationAI

A vendor patch is available. Apply the latest security update as soon as possible. Apply principle of least privilege, validate privilege transitions, implement proper role separation.